Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.20.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2020
Dec. 31, 2019
Current Assets    
Cash and cash equivalents $ 11,970,217 $ 16,966,168
Accounts receivable 242
Prepaid expenses 753,047 267,518
Other current assets 377,780 322,593
Total Current Assets 13,101,286 17,556,279
Property and equipment, net 3,097,465 2,981,225
Operating lease right-of-use assets 330,131 381,483
Intangible assets, net 346,030 372,305
Total Assets 16,874,912 21,291,292
Current Liabilities    
Accounts payable 1,487,769 627,253
Accrued liabilities 2,139,085 2,168,588
Management and directors' fees payable 55,660 21,979
Current portion of long-term debt 612,655 647,569
Current portion of finance lease liabilities 74,033 97,946
Current portion of operating lease liabilities 226,697 257,244
Current portion of grant repayable 38,583 39,295
Total Current Liabilities 4,634,482 3,859,874
Long-term debt, net of current portion 2,063,100 2,195,278
Finance lease liabilities, net of current portion 583,333 607,708
Operating lease liabilities, net of current portion 112,209 131,875
Grant repayable, net of current portion 296,431 297,991
Total Liabilities 7,689,555 7,092,726
STOCKHOLDERS' EQUITY    
Common Stock Authorized: 100,000,000 shares of common stock, at $0.001 par value Issued and outstanding: 41,206,632 shares and 41,125,303 shares, respectively 41,207 41,125
Additional paid-in capital 104,325,749 103,853,627
Accumulated other comprehensive income 499,596 125,670
Accumulated deficit (95,681,195) (89,821,856)
Total VolitionRx Limited Stockholders' Equity 9,194,924 14,198,566
Non-controlling interest (9,567)
Total Stockholders' Equity 9,185,357 14,198,566
Total Liabilities and Stockholders' Equity $ 16,874,912 $ 21,291,292